文献速递性腺与生殖内分泌

雌酮是70岁及以上女性循环雌二醇的强预测因子

Estrone Is a Strong Predictor of Circulating Estradiol in Women Age 70 Years and Older.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

这项基于社区的横断面研究纳入5325名未使用性激素、抗雄/雌激素、糖皮质激素或降糖治疗的女性(平均年龄75.1岁),用液相色谱-串联质谱法测定性激素。66.1%的女性雌二醇低于检测限,雌酮和可检测雌二醇的中位数分别为181.2 pmol/L和22.0 pmol/L。包含年龄、BMI、雌酮和睾酮的线性回归模型解释总雌二醇变异的20.9%,但仅比单用雌酮多解释1.2%。

要点

  • 66.1%的70岁及以上女性雌二醇低于检测限,雌酮仅0.9%低于检测限。
  • 可检测雌二醇女性的雌酮中位数为181.2 pmol/L,可检测雌二醇中位数为22.0 pmol/L。
  • 包含年龄、BMI、雌酮和睾酮的模型解释总雌二醇变异的20.9%,仅比单用雌酮多1.2%。

核心结论

  • 研究结果支持雌酮是主要的循环雌激素,并表明绝经后女性雌酮与雌二醇浓度之间存在强关联。
  • 结合先前关于雌酮与健康结局关联的证据,作者认为在考察绝经后女性雌激素水平与健康结局关联的研究中应纳入雌酮。

研究设计与样本

  • 横断面、基于社区的研究,共纳入5325名女性,平均年龄75.1岁(±4.2岁),未使用任何性激素、抗雄激素/雌激素、糖皮质激素或降糖治疗。
  • 性激素采用液相色谱-串联质谱法测定,低于检测限(雌二醇11 pmol/L [3 pg/mL])的值赋值为检测限/√2以估算总雌二醇。

主要发现

  • 雌二醇和雌酮低于检测限的女性比例分别为66.1%和0.9%。
  • 雌酮和可检测雌二醇的中位数(十分位间距)分别为181.2 pmol/L(范围88.7-347.6 pmol/L)和22.0 pmol/L(范围11.0-58.7 pmol/L)。
  • 雌二醇不可检测组 vs 可检测组:中位年龄74.1岁 vs 73.8岁(P = .02),中位BMI 26.8 kg/m2 vs 28.5 kg/m2(P < .001),雌酮、睾酮和DHEA浓度更低(P < .001)。
  • 包含年龄、BMI、雌酮和睾酮的线性回归模型解释总雌二醇变异的20.9%,但仅比单用雌酮多解释1.2%。
  • 在可检测雌二醇的女性亚组中,雌酮和睾酮对模型有显著贡献(r2 = 0.162,P < .001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: After menopause, estradiol (E2) is predominately an intracrine hormone circulating in very low serum concentrations. OBJECTIVE: The objective of this work is to examine determinants of E2 concentrations in women beyond age 70 years. DESIGN AND SETTING: A cross-sectional, community-based study was conducted. PARTICIPANTS: A total of 5325 women participated, with a mean age of 75.1 years (± 4.2 years) and not using any sex steroid, antiandrogen/estrogen, glucocorticoid, or antiglycemic therapy. MAIN OUTCOME MEASURES: Sex steroids were measured by liquid chromatography-tandem mass spectrometry. Values below the limit of detection (LOD; E2 11 pmol/L [3 pg/mL] were assigned a value of LOD/√2 to estimate total E2. RESULTS: E2 and estrone (E1) were below the LOD in 66.1% and 0.9% of women, respectively. The median (interdecile ranges) for E1 and detectable E2 were 181.2 pmol/L (range, 88.7-347.6 pmol/L) and 22.0 pmol/L (range, 11.0-58.7 pmol/L). Women with undetectable E2 vs detectable E2 were older (median age 74.1 years vs 73.8, P = .02), leaner (median body mass index [BMI] 26.8 kg/m2 vs 28.5, P < .001), and had lower E1, testosterone and DHEA concentrations (P < .001). A linear regression model, including age, BMI, E1, and testosterone, explained 20.9% of the variation in total E2, but explained only an additional 1.2% of variation over E1 alone. E1 and testosterone made significant contributions (r2 = 0.162, P < .001) in a model for the subset of women with detectable E2. CONCLUSIONS: Our findings support E1 as a principal circulating estrogen and demonstrate a robust association between E1 and E2 concentrations in postmenopausal women. Taken together with prior evidence for associations between E1 and health outcomes, E1 should be included in studies examining associations between estrogen levels and health outcomes in postmenopausal women.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Davis SR, Martinez-Garcia A, Robinson PJ, et al. Estrone Is a Strong Predictor of Circulating Estradiol in Women Age 70 Years and Older. J Clin Endocrinol Metab. 2020. PMID: 32614391. doi:10.1210/clinem/dgaa429

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。